Simcere Pharmaceutical Group Limited (2096.HK)
Develops cancer and infectious disease drugs for the Chinese market.
12.86+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+2.9%
The outlook
Simcere Pharmaceutical (2096.HK) trades at 12.86 with strong analyst backing and sits comfortably above both its 50- and 200-day moving averages, reflecting upward momentum. The stock is positioned midway through its 52-week range, and the average analyst price target sits roughly 39% above the current price. Trailing valuation stands at a P/E of 20.4.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 4 analysts
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Price targetAvg target +39% vs current price
Analyst price target
~12-month · 4 analysts17.85average target+38.8% vs now
Now 12.86
Low 12.42High 21.65
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$33.03B
52-wk high
15.08
52-wk low
9.07
50-day avg
10.90
200-day avg
12.11
Trailing P/E
20.4